Loading…
Differential local and systemic regulation of the murine chemokines KC and MIP2
We characterized the relative biological activity and expression of two murine chemokines that may serve as functional homologues for human IL-8, KC, and macrophage inflammatory protein 2 (MIP2). Recombinant chemokines were produced in bacterial expression systems and antibodies specific for KC or M...
Saved in:
Published in: | Shock (Augusta, Ga.) Ga.), 2001-04, Vol.15 (4), p.278-284 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c389t-8b8bb5daf07383f1e5ff3e8346558c958f7cdea92a4146a9da8a3779057348513 |
---|---|
cites | |
container_end_page | 284 |
container_issue | 4 |
container_start_page | 278 |
container_title | Shock (Augusta, Ga.) |
container_volume | 15 |
creator | CALL, Douglas R NEMZEK, Jean A EBONG, Samuel J BOLGOS, Gerald R NEWCOMB, David E WOLLENBERG, Gordon K REMICK, Daniel G |
description | We characterized the relative biological activity and expression of two murine chemokines that may serve as functional homologues for human IL-8, KC, and macrophage inflammatory protein 2 (MIP2). Recombinant chemokines were produced in bacterial expression systems and antibodies specific for KC or MIP2 were raised. In vitro assays showed that KC elicited 4-fold greater neutrophil chemotaxis compared with MIP2, while MIP2 elicited significantly greater release of elastase. Lipopolysaccharide- (LPS) stimulated macrophages (8 h) secreted more MIP2 (approximately 10 ng/mL) compared with KC (approximately 4 ng/ml) and expression of either murine chemokine was independent of TNFalpha or IL-1beta production. Thioglycollate (thio) and glycogen (gly) induced peritonitis produced more KC (thio = 7.1 and gly = 2.5 ng/mL) in the peritoneum compared with MIP2 (thio = 4.5 and gly = 0.3 ng/mL). Plasma KC levels were very high after either challenge (approximately 24 ng/mL), which was >50-fold more than the systemic increase in MIP2 (approximately 0.3 ng/mL). Our data demonstrate that while KC and MIP2 have similar in vitro production characteristics, KC appears to be a more potent and systemically distributed chemokine during acute in vivo inflammation, while MIP2 expression appears limited to localized expression. |
doi_str_mv | 10.1097/00024382-200115040-00005 |
format | article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1097_00024382_200115040_00005</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>11303726</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-8b8bb5daf07383f1e5ff3e8346558c958f7cdea92a4146a9da8a3779057348513</originalsourceid><addsrcrecordid>eNpFkE1PAyEURYnR2Fr9C4bE9SjwoMDS1K_GmrrQ9YRhwI7ORwPTRf-9dFrrBi7knpeXgxCm5JYSLe8IIYyDYhkjhFJBOMnSFxEnaEzF7iEoP02ZSMgYMDZCFzF-D5CW52hEKRCQbDpGy4fKexdc21emxnVn02naEsdt7F1TWRzc16Y2fdW1uPO4XzncbELVOmxXrul-Uor4dTYwb_N3donOvKmjuzrcE_T59Pgxe8kWy-f57H6RWVC6z1ShikKUxqcNFXjqhPfgFPCpEMpqoby0pTOaGU751OjSKANSaiIkcCUoTJDaz7WhizE4n69D1ZiwzSnJd47yP0f50VE-OEro9R5db4rGlf_gQUoq3BwKJiYfPpjWVvHY08AkE_ALhARtKg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Differential local and systemic regulation of the murine chemokines KC and MIP2</title><source>Freely Accessible Journals</source><creator>CALL, Douglas R ; NEMZEK, Jean A ; EBONG, Samuel J ; BOLGOS, Gerald R ; NEWCOMB, David E ; WOLLENBERG, Gordon K ; REMICK, Daniel G</creator><creatorcontrib>CALL, Douglas R ; NEMZEK, Jean A ; EBONG, Samuel J ; BOLGOS, Gerald R ; NEWCOMB, David E ; WOLLENBERG, Gordon K ; REMICK, Daniel G</creatorcontrib><description>We characterized the relative biological activity and expression of two murine chemokines that may serve as functional homologues for human IL-8, KC, and macrophage inflammatory protein 2 (MIP2). Recombinant chemokines were produced in bacterial expression systems and antibodies specific for KC or MIP2 were raised. In vitro assays showed that KC elicited 4-fold greater neutrophil chemotaxis compared with MIP2, while MIP2 elicited significantly greater release of elastase. Lipopolysaccharide- (LPS) stimulated macrophages (8 h) secreted more MIP2 (approximately 10 ng/mL) compared with KC (approximately 4 ng/ml) and expression of either murine chemokine was independent of TNFalpha or IL-1beta production. Thioglycollate (thio) and glycogen (gly) induced peritonitis produced more KC (thio = 7.1 and gly = 2.5 ng/mL) in the peritoneum compared with MIP2 (thio = 4.5 and gly = 0.3 ng/mL). Plasma KC levels were very high after either challenge (approximately 24 ng/mL), which was >50-fold more than the systemic increase in MIP2 (approximately 0.3 ng/mL). Our data demonstrate that while KC and MIP2 have similar in vitro production characteristics, KC appears to be a more potent and systemically distributed chemokine during acute in vivo inflammation, while MIP2 expression appears limited to localized expression.</description><identifier>ISSN: 1073-2322</identifier><identifier>EISSN: 1540-0514</identifier><identifier>DOI: 10.1097/00024382-200115040-00005</identifier><identifier>PMID: 11303726</identifier><language>eng</language><publisher>Augusta, GA: BioMedical Press</publisher><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Animals ; Biological and medical sciences ; Blotting, Western ; Chemokine CXCL1 ; Chemokine CXCL2 ; Chemokines - genetics ; Chemokines - metabolism ; Chemokines - pharmacology ; Chemokines, CXC ; Chemotactic Factors - genetics ; Chemotactic Factors - metabolism ; Chemotactic Factors - pharmacology ; Chemotaxis, Leukocyte - drug effects ; Emergency and intensive care: infection, septic shock ; Enzyme-Linked Immunosorbent Assay ; Gene Expression Regulation ; Glycogen - toxicity ; Growth Substances - genetics ; Growth Substances - metabolism ; Growth Substances - pharmacology ; Intensive care medicine ; Intercellular Signaling Peptides and Proteins ; Interleukin-6 - analysis ; Leukocyte Elastase - secretion ; Lipopolysaccharides - pharmacology ; Macrophage Activation - drug effects ; Macrophages, Peritoneal - secretion ; Medical sciences ; Mice ; Mice, Inbred BALB C ; Models, Animal ; Neutrophils - drug effects ; Peritonitis - chemically induced ; Peritonitis - genetics ; Peritonitis - immunology ; Peritonitis - metabolism ; Rabbits ; Recombinant Fusion Proteins - pharmacology ; Thioglycolates - toxicity ; Tumor Necrosis Factor-alpha - analysis</subject><ispartof>Shock (Augusta, Ga.), 2001-04, Vol.15 (4), p.278-284</ispartof><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-8b8bb5daf07383f1e5ff3e8346558c958f7cdea92a4146a9da8a3779057348513</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=932725$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11303726$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>CALL, Douglas R</creatorcontrib><creatorcontrib>NEMZEK, Jean A</creatorcontrib><creatorcontrib>EBONG, Samuel J</creatorcontrib><creatorcontrib>BOLGOS, Gerald R</creatorcontrib><creatorcontrib>NEWCOMB, David E</creatorcontrib><creatorcontrib>WOLLENBERG, Gordon K</creatorcontrib><creatorcontrib>REMICK, Daniel G</creatorcontrib><title>Differential local and systemic regulation of the murine chemokines KC and MIP2</title><title>Shock (Augusta, Ga.)</title><addtitle>Shock</addtitle><description>We characterized the relative biological activity and expression of two murine chemokines that may serve as functional homologues for human IL-8, KC, and macrophage inflammatory protein 2 (MIP2). Recombinant chemokines were produced in bacterial expression systems and antibodies specific for KC or MIP2 were raised. In vitro assays showed that KC elicited 4-fold greater neutrophil chemotaxis compared with MIP2, while MIP2 elicited significantly greater release of elastase. Lipopolysaccharide- (LPS) stimulated macrophages (8 h) secreted more MIP2 (approximately 10 ng/mL) compared with KC (approximately 4 ng/ml) and expression of either murine chemokine was independent of TNFalpha or IL-1beta production. Thioglycollate (thio) and glycogen (gly) induced peritonitis produced more KC (thio = 7.1 and gly = 2.5 ng/mL) in the peritoneum compared with MIP2 (thio = 4.5 and gly = 0.3 ng/mL). Plasma KC levels were very high after either challenge (approximately 24 ng/mL), which was >50-fold more than the systemic increase in MIP2 (approximately 0.3 ng/mL). Our data demonstrate that while KC and MIP2 have similar in vitro production characteristics, KC appears to be a more potent and systemically distributed chemokine during acute in vivo inflammation, while MIP2 expression appears limited to localized expression.</description><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Blotting, Western</subject><subject>Chemokine CXCL1</subject><subject>Chemokine CXCL2</subject><subject>Chemokines - genetics</subject><subject>Chemokines - metabolism</subject><subject>Chemokines - pharmacology</subject><subject>Chemokines, CXC</subject><subject>Chemotactic Factors - genetics</subject><subject>Chemotactic Factors - metabolism</subject><subject>Chemotactic Factors - pharmacology</subject><subject>Chemotaxis, Leukocyte - drug effects</subject><subject>Emergency and intensive care: infection, septic shock</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Gene Expression Regulation</subject><subject>Glycogen - toxicity</subject><subject>Growth Substances - genetics</subject><subject>Growth Substances - metabolism</subject><subject>Growth Substances - pharmacology</subject><subject>Intensive care medicine</subject><subject>Intercellular Signaling Peptides and Proteins</subject><subject>Interleukin-6 - analysis</subject><subject>Leukocyte Elastase - secretion</subject><subject>Lipopolysaccharides - pharmacology</subject><subject>Macrophage Activation - drug effects</subject><subject>Macrophages, Peritoneal - secretion</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Models, Animal</subject><subject>Neutrophils - drug effects</subject><subject>Peritonitis - chemically induced</subject><subject>Peritonitis - genetics</subject><subject>Peritonitis - immunology</subject><subject>Peritonitis - metabolism</subject><subject>Rabbits</subject><subject>Recombinant Fusion Proteins - pharmacology</subject><subject>Thioglycolates - toxicity</subject><subject>Tumor Necrosis Factor-alpha - analysis</subject><issn>1073-2322</issn><issn>1540-0514</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNpFkE1PAyEURYnR2Fr9C4bE9SjwoMDS1K_GmrrQ9YRhwI7ORwPTRf-9dFrrBi7knpeXgxCm5JYSLe8IIYyDYhkjhFJBOMnSFxEnaEzF7iEoP02ZSMgYMDZCFzF-D5CW52hEKRCQbDpGy4fKexdc21emxnVn02naEsdt7F1TWRzc16Y2fdW1uPO4XzncbELVOmxXrul-Uor4dTYwb_N3donOvKmjuzrcE_T59Pgxe8kWy-f57H6RWVC6z1ShikKUxqcNFXjqhPfgFPCpEMpqoby0pTOaGU751OjSKANSaiIkcCUoTJDaz7WhizE4n69D1ZiwzSnJd47yP0f50VE-OEro9R5db4rGlf_gQUoq3BwKJiYfPpjWVvHY08AkE_ALhARtKg</recordid><startdate>20010401</startdate><enddate>20010401</enddate><creator>CALL, Douglas R</creator><creator>NEMZEK, Jean A</creator><creator>EBONG, Samuel J</creator><creator>BOLGOS, Gerald R</creator><creator>NEWCOMB, David E</creator><creator>WOLLENBERG, Gordon K</creator><creator>REMICK, Daniel G</creator><general>BioMedical Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20010401</creationdate><title>Differential local and systemic regulation of the murine chemokines KC and MIP2</title><author>CALL, Douglas R ; NEMZEK, Jean A ; EBONG, Samuel J ; BOLGOS, Gerald R ; NEWCOMB, David E ; WOLLENBERG, Gordon K ; REMICK, Daniel G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-8b8bb5daf07383f1e5ff3e8346558c958f7cdea92a4146a9da8a3779057348513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Blotting, Western</topic><topic>Chemokine CXCL1</topic><topic>Chemokine CXCL2</topic><topic>Chemokines - genetics</topic><topic>Chemokines - metabolism</topic><topic>Chemokines - pharmacology</topic><topic>Chemokines, CXC</topic><topic>Chemotactic Factors - genetics</topic><topic>Chemotactic Factors - metabolism</topic><topic>Chemotactic Factors - pharmacology</topic><topic>Chemotaxis, Leukocyte - drug effects</topic><topic>Emergency and intensive care: infection, septic shock</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Gene Expression Regulation</topic><topic>Glycogen - toxicity</topic><topic>Growth Substances - genetics</topic><topic>Growth Substances - metabolism</topic><topic>Growth Substances - pharmacology</topic><topic>Intensive care medicine</topic><topic>Intercellular Signaling Peptides and Proteins</topic><topic>Interleukin-6 - analysis</topic><topic>Leukocyte Elastase - secretion</topic><topic>Lipopolysaccharides - pharmacology</topic><topic>Macrophage Activation - drug effects</topic><topic>Macrophages, Peritoneal - secretion</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Models, Animal</topic><topic>Neutrophils - drug effects</topic><topic>Peritonitis - chemically induced</topic><topic>Peritonitis - genetics</topic><topic>Peritonitis - immunology</topic><topic>Peritonitis - metabolism</topic><topic>Rabbits</topic><topic>Recombinant Fusion Proteins - pharmacology</topic><topic>Thioglycolates - toxicity</topic><topic>Tumor Necrosis Factor-alpha - analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>CALL, Douglas R</creatorcontrib><creatorcontrib>NEMZEK, Jean A</creatorcontrib><creatorcontrib>EBONG, Samuel J</creatorcontrib><creatorcontrib>BOLGOS, Gerald R</creatorcontrib><creatorcontrib>NEWCOMB, David E</creatorcontrib><creatorcontrib>WOLLENBERG, Gordon K</creatorcontrib><creatorcontrib>REMICK, Daniel G</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Shock (Augusta, Ga.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>CALL, Douglas R</au><au>NEMZEK, Jean A</au><au>EBONG, Samuel J</au><au>BOLGOS, Gerald R</au><au>NEWCOMB, David E</au><au>WOLLENBERG, Gordon K</au><au>REMICK, Daniel G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differential local and systemic regulation of the murine chemokines KC and MIP2</atitle><jtitle>Shock (Augusta, Ga.)</jtitle><addtitle>Shock</addtitle><date>2001-04-01</date><risdate>2001</risdate><volume>15</volume><issue>4</issue><spage>278</spage><epage>284</epage><pages>278-284</pages><issn>1073-2322</issn><eissn>1540-0514</eissn><abstract>We characterized the relative biological activity and expression of two murine chemokines that may serve as functional homologues for human IL-8, KC, and macrophage inflammatory protein 2 (MIP2). Recombinant chemokines were produced in bacterial expression systems and antibodies specific for KC or MIP2 were raised. In vitro assays showed that KC elicited 4-fold greater neutrophil chemotaxis compared with MIP2, while MIP2 elicited significantly greater release of elastase. Lipopolysaccharide- (LPS) stimulated macrophages (8 h) secreted more MIP2 (approximately 10 ng/mL) compared with KC (approximately 4 ng/ml) and expression of either murine chemokine was independent of TNFalpha or IL-1beta production. Thioglycollate (thio) and glycogen (gly) induced peritonitis produced more KC (thio = 7.1 and gly = 2.5 ng/mL) in the peritoneum compared with MIP2 (thio = 4.5 and gly = 0.3 ng/mL). Plasma KC levels were very high after either challenge (approximately 24 ng/mL), which was >50-fold more than the systemic increase in MIP2 (approximately 0.3 ng/mL). Our data demonstrate that while KC and MIP2 have similar in vitro production characteristics, KC appears to be a more potent and systemically distributed chemokine during acute in vivo inflammation, while MIP2 expression appears limited to localized expression.</abstract><cop>Augusta, GA</cop><pub>BioMedical Press</pub><pmid>11303726</pmid><doi>10.1097/00024382-200115040-00005</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1073-2322 |
ispartof | Shock (Augusta, Ga.), 2001-04, Vol.15 (4), p.278-284 |
issn | 1073-2322 1540-0514 |
language | eng |
recordid | cdi_crossref_primary_10_1097_00024382_200115040_00005 |
source | Freely Accessible Journals |
subjects | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Animals Biological and medical sciences Blotting, Western Chemokine CXCL1 Chemokine CXCL2 Chemokines - genetics Chemokines - metabolism Chemokines - pharmacology Chemokines, CXC Chemotactic Factors - genetics Chemotactic Factors - metabolism Chemotactic Factors - pharmacology Chemotaxis, Leukocyte - drug effects Emergency and intensive care: infection, septic shock Enzyme-Linked Immunosorbent Assay Gene Expression Regulation Glycogen - toxicity Growth Substances - genetics Growth Substances - metabolism Growth Substances - pharmacology Intensive care medicine Intercellular Signaling Peptides and Proteins Interleukin-6 - analysis Leukocyte Elastase - secretion Lipopolysaccharides - pharmacology Macrophage Activation - drug effects Macrophages, Peritoneal - secretion Medical sciences Mice Mice, Inbred BALB C Models, Animal Neutrophils - drug effects Peritonitis - chemically induced Peritonitis - genetics Peritonitis - immunology Peritonitis - metabolism Rabbits Recombinant Fusion Proteins - pharmacology Thioglycolates - toxicity Tumor Necrosis Factor-alpha - analysis |
title | Differential local and systemic regulation of the murine chemokines KC and MIP2 |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T00%3A18%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differential%20local%20and%20systemic%20regulation%20of%20the%20murine%20chemokines%20KC%20and%20MIP2&rft.jtitle=Shock%20(Augusta,%20Ga.)&rft.au=CALL,%20Douglas%20R&rft.date=2001-04-01&rft.volume=15&rft.issue=4&rft.spage=278&rft.epage=284&rft.pages=278-284&rft.issn=1073-2322&rft.eissn=1540-0514&rft_id=info:doi/10.1097/00024382-200115040-00005&rft_dat=%3Cpubmed_cross%3E11303726%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c389t-8b8bb5daf07383f1e5ff3e8346558c958f7cdea92a4146a9da8a3779057348513%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/11303726&rfr_iscdi=true |